Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial

Mustafa Khasraw,Adrian Lee, Sally McCowatt, Zoltan Kerestes,Marc E. Buyse,Michael Back,Ganessan Kichenadasse,Stephen Ackland,Helen Wheeler

Journal of Neuro-Oncology（2016）

引用 39|浏览1

暂无评分

关键词

Glioblastoma,Radiotherapy,Cilengitide,Temozolomide,Procarbazine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要